Skip to main content

Study Uses Pharmacogenomic Data from Electronic Health Record

Nurse Talking with Senior Patient Provider in Home with Senior Patients

Mayo Clinic researchers conducted the “Right Drug, Right Dose, Right Time: Using Genomic Data to Individualize Treatment” (RIGHT) Protocol study to use patients’ genetic information from their electronic health record (EHR) to try to improve future outcomes. In the study’s first phase, 1,013 Mayo Clinic patients were screened for 84 genetic variants known to influence drug response, along with five genes known to have clinical influence in each patient’s EHR. This information may be tapped for future prescription of one of 17 drugs, triggering an alert for the clinicians to consider an alternative or altering the dosage in light of an actionable gene variant. This study is now being expanded to include 10,000 patients for a larger sample size and greater clinical value. Read more about the study at the Huffington Post article.